Literature DB >> 2745253

Comparison of two oral formulations of vancomycin for treatment of diarrhoea associated with Clostridium difficile.

D R Baird.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2745253     DOI： 10.1093/jac/23.1.167

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

Review 1.  Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Authors:  Edward C Oldfield; Edward C Oldfield; David A Johnson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

2.  A Prospective Pilot Study on the Systemic Absorption of Oral Vancomycin in Children With Colitis.

Authors:  James W Antoon; Margaret Hall; Diana Metropulos; Michael J Steiner; Ravi Jhaveri; Jacob A Lohr
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Sep-Oct

Review 3.  Does oral vancomycin use necessitate therapeutic drug monitoring?

Authors:  Nevio Cimolai
Journal:  Infection       Date:  2019-11-11       Impact factor: 3.553

Review 4.  Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection.

Authors:  Fawziah Marra; Karen Ng
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

5.  Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection.

Authors:  Milagros Gonzales; Jacques Pepin; Eric H Frost; Julie C Carrier; Stephanie Sirard; Louis-Charles Fortier; Louis Valiquette
Journal:  BMC Infect Dis       Date:  2010-12-30       Impact factor: 3.090

6.  The Effects of Fasting and Massive Diarrhea on Absorption of Enteral Vancomycin in Critically Ill Patients: A Retrospective Observational Study.

Authors:  Takehiko Oami; Noriyuki Hattori; Yosuke Matsumura; Eizo Watanabe; Ryuzo Abe; Taku Oshima; Waka Takahashi; Shingo Yamazaki; Tatsuya Suzuki; Shigeto Oda
Journal:  Front Med (Lausanne)       Date:  2017-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.